Literature DB >> 2142151

Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.

Y Harada1, M Sakatsume, M Taniguchi.   

Abstract

We investigated the ability of GM3-lactone liposomes to induce anti-melanoma T cell responses in mice. GM3-lactone liposomes, like murine B16 melanoma cells, induced anti-melanoma cytotoxic T cells (CTL) and also suppressor T cells (Ts). A small dose of GM3-lactone (0.0003 micrograms/ml) was enough to generate CTL in the in vitro primary response, whereas relatively large amounts of the antigen (0.03-0.3 microgram/ml) were required for anti-melanoma Ts induction. As the epitope for anti-melanoma Ts is NeuAc but not NeuGc residue on GM3, and anti-melanoma CTL are effectively induced by either GM3(NeuAc) or GM3(NeuGc)-lactone liposomes, GM3(NeuGc)-lactone or GM3(NeuGc) liposomes have potent activity as an artificial melanoma antigen to induce anti-melanoma CTL in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142151      PMCID: PMC5918042          DOI: 10.1111/j.1349-7006.1990.tb02579.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


cytotoxic T lymphocytes suppressor T lymphocytes mitomycin C NeuGc‐α2‐3Galβ1‐4Glc; GM3(NeuAc), NeuAcα2‐3Galβ1‐4Glc
  12 in total

1.  Immunological surveillance in neoplasia.

Authors:  F M Burnet
Journal:  Transplant Rev       Date:  1971

2.  Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.

Authors:  L D Cahan; R F Irie; R Singh; A Cassidenti; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  Cytotoxic T lymphocytes induced by syngeneic mouse melanoma cells recognize human melanomas.

Authors:  S Wakabayashi; M Taniguchi; T Tokuhisa; H Tomioka; S Okamoto
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.

Authors:  Y Hirabayashi; A Hamaoka; M Matsumoto; T Matsubara; M Tagawa; S Wakabayashi; M Taniguchi
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

5.  An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.

Authors:  T Dohi; G Nores; S Hakomori
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

6.  Ganglioside GM2 as a human tumor antigen (OFA-I-1).

Authors:  T Tai; J C Paulson; L D Cahan; R F Irie
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Escape mechanisms of melanoma from immune system by soluble melanoma antigen.

Authors:  K Takahashi; K Ono; Y Hirabayashi; M Taniguchi
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

8.  Mouse melanoma antigen recognized by Lyt-2- and L3T4- cytotoxic T-lymphocytes.

Authors:  K Ono; K Takahashi; Y Hirabayashi; T Itoh; Y Hiraga; M Taniguchi
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

9.  Shared antigenic determinant expressed on various mammalian melanoma cells.

Authors:  M Taniguchi; S Wakabayashi
Journal:  Gan       Date:  1984-05

10.  Density of GM3 with normal primary structure determines mouse melanoma antigenicity; a new concept of tumor antigen.

Authors:  Y Harada; M Sakatsume; G A Nores; S Hakomori; M Taniguchi
Journal:  Jpn J Cancer Res       Date:  1989-10
View more
  1 in total

1.  Human dendritic cell activation induced by a permannosylated dendron containing an antigenic GM3-lactone mimetic.

Authors:  Renato Ribeiro-Viana; Elena Bonechi; Javier Rojo; Clara Ballerini; Giuseppina Comito; Barbara Richichi; Cristina Nativi
Journal:  Beilstein J Org Chem       Date:  2014-06-10       Impact factor: 2.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.